| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PGEN | Common Stock | Award | $24,999 | +17,605 | $1.42 | 17,605 | 05 Jul 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PGEN | Restricted Stock Units | Award | $0 | +126,760 | $0.000000 | 126,760 | 05 Jul 2024 | Common Stock | 126,760 | Direct | F2, F3 | ||
| transaction | PGEN | Option to Purchase Common Stock (Right to Buy) | Award | $0 | +147,540 | $0.000000 | 147,540 | 05 Jul 2024 | Common Stock | 147,540 | $1.42 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The shares were issued to the reporting person in lieu of a pro-rated annual retainer of $24,999. |
| F2 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| F3 | The RSUs vest in full on July 5, 2025. |
| F4 | The options vest in four equal installments of 25% on each of July 5, 2025, July 5, 2026, July 5, 2027 and July 5, 2028. |